215 related articles for article (PubMed ID: 8748871)
1. Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage.
Porchet F; Chioléro R; de Tribolet N
Acta Neurochir (Wien); 1995; 137(1-2):62-9. PubMed ID: 8748871
[TBL] [Abstract][Full Text] [Related]
2. Does nimodipine influence sex difference in outcome after aneurysmal subarachnoid haemorrhage?
Hauerberg J; Rosenørn J; Skriver EB
Acta Neurochir (Wien); 1996; 138(10):1168-71. PubMed ID: 8955435
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic effects of intravenous nimodipine following aneurysmal subarachnoid haemorrhage: implications for monitoring.
Radhakrishnan D; Menon DK
Anaesthesia; 1997 May; 52(5):489-91. PubMed ID: 9165970
[TBL] [Abstract][Full Text] [Related]
4. Poor Utilization of Nimodipine in Aneurysmal Subarachnoid Hemorrhage.
Hajizadeh Barfejani A; Rabinstein AA; Wijdicks EFM; Clark SL
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2155-2158. PubMed ID: 31103551
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Arterial Hypotension in Patients Receiving Peroral or Continuous Intra-arterial Nimodipine After Aneurysmal or Perimesencephalic Subarachnoid Hemorrhage.
Kieninger M; Gruber M; Knott I; Dettmer K; Oefner PJ; Bele S; Wendl C; Tuemmler S; Graf B; Eissnert C
Neurocrit Care; 2019 Aug; 31(1):32-39. PubMed ID: 30725331
[TBL] [Abstract][Full Text] [Related]
6. Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage.
Sandow N; Diesing D; Sarrafzadeh A; Vajkoczy P; Wolf S
Neurocrit Care; 2016 Aug; 25(1):29-39. PubMed ID: 26690937
[TBL] [Abstract][Full Text] [Related]
7. In brief: nimodipine oral solution (Nymalize).
Med Lett Drugs Ther; 2013 Aug; 55(1423):68. PubMed ID: 23959389
[No Abstract] [Full Text] [Related]
8. Dangers of outpatient nimodipine use after spontaneous subarachnoid hemorrhage in accordance with the Comprehensive Stroke Center guidelines.
Chen CJ; Turnage C; Sokolowski JD; Kumar JS; Kalani MY; Park MS
J Clin Neurosci; 2018 Jun; 52():151-152. PubMed ID: 29656002
[TBL] [Abstract][Full Text] [Related]
9. Nimodipine-associated standard dose reductions and neurologic outcomes after aneurysmal subarachnoid hemorrhage: the era of pharmacogenomics.
Vázquez-Medina A; Turnbull MT; James CL; Cowart JB; Lesser E; Carter RE; Ross OA; Miller DA; Meschia JF; De Jesús Espinosa A; Weinshilboum R; Freeman WD
Pharmacogenomics J; 2024 Jun; 24(4):19. PubMed ID: 38890281
[TBL] [Abstract][Full Text] [Related]
10. Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)].
Hänggi D; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Schmutzhard E; Faleck HJ; Ng D; Saville BR; Macdonald RL;
Neurocrit Care; 2019 Feb; 30(1):88-97. PubMed ID: 30014184
[TBL] [Abstract][Full Text] [Related]
11. NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage.
Hänggi D; Etminan N; Macdonald RL; Steiger HJ; Mayer SA; Aldrich F; Diringer MN; Hoh BL; Mocco J; Strange P; Faleck HJ; Miller M
Neurocrit Care; 2015 Oct; 23(2):274-84. PubMed ID: 25678453
[TBL] [Abstract][Full Text] [Related]
12. The haemodynamic effect of transcranial Doppler-guided high-dose nimodipine treatment in established vasospasm after subarachnoid haemorrhage.
Zygmunt SC; Delgado-Zygmunt TJ
Acta Neurochir (Wien); 1995; 135(3-4):179-85. PubMed ID: 8748811
[TBL] [Abstract][Full Text] [Related]
13. The effect of nimodipine on cerebral oxygenation in patients with poor-grade subarachnoid hemorrhage.
Stiefel MF; Heuer GG; Abrahams JM; Bloom S; Smith MJ; Maloney-Wilensky E; Grady MS; LeRoux PD
J Neurosurg; 2004 Oct; 101(4):594-9. PubMed ID: 15481712
[TBL] [Abstract][Full Text] [Related]
14. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.
Pickard JD; Murray GD; Illingworth R; Shaw MD; Teasdale GM; Foy PM; Humphrey PR; Lang DA; Nelson R; Richards P
BMJ; 1989 Mar; 298(6674):636-42. PubMed ID: 2496789
[TBL] [Abstract][Full Text] [Related]
16. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration.
Kronvall E; Undrén P; Romner B; Säveland H; Cronqvist M; Nilsson OG
J Neurosurg; 2009 Jan; 110(1):58-63. PubMed ID: 18847340
[TBL] [Abstract][Full Text] [Related]
17. Outcome of Oral and Intra-arterial Nimodipine Administration After Aneurysmal Subarachnoid Haemorrhage - A Single-centre Study.
Ehrlich G; Kirschning T; Wenz H; Hegewald AA; Neumaier-Probst E; Seiz-Rosenhagen M
In Vivo; 2019; 33(6):1967-1975. PubMed ID: 31662526
[TBL] [Abstract][Full Text] [Related]
18. Impact of Early Versus Late Intravenous Followed by Oral Nimodipine Treatment on the Occurrence of Delayed Cerebral Ischemia Among Patients With Aneurysm Subarachnoid Hemorrhage.
Samseethong T; Suansanae T; Veerasarn K; Liengudom A; Suthisisang C
Ann Pharmacother; 2018 Nov; 52(11):1061-1069. PubMed ID: 29783859
[TBL] [Abstract][Full Text] [Related]
19. Nimodipine treatment of subarachnoid hemorrhage.
Laursen J; Jensen F; Mikkelsen E; Jakobsen P
Clin Neurol Neurosurg; 1988; 90(4):329-37. PubMed ID: 3233859
[TBL] [Abstract][Full Text] [Related]
20. Successful prevention of neurological deficit in SAH patients with 2-chlorodeoxyadenosine.
Ryba M; Grieb P; Pastuszko M; Bidziński J; Andrychowski J; Dziewiecki C; Bojarski P; Królicki L
Acta Neurochir (Wien); 1993; 124(2-4):61-5. PubMed ID: 7905693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
